British Evonetix Ltd has added US$$24m to its existing US$30m Series B financing round. The new financing was led by existing investor Foresite Capital.
https://european-biotechnology.com/wp-content/uploads/2024/04/evonteix-home-silicon-array.jpeg571800Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-02-07 17:13:432024-07-15 12:58:38Evonetix extends Series B financing to US$54m